These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Role of insulin-like growth factor (IGF)-1 in the modulation of renal haemodynamics in Type I diabetic patients. Bacci S; De Cosmo S; Garruba M; Placentino G; Liuzzi A; Barbano F; Di Giorgio A; Trischitta V; Viberti GC Diabetologia; 2000 Jul; 43(7):922-6. PubMed ID: 10952466 [TBL] [Abstract][Full Text] [Related]
4. Growth hormone, insulin-like growth factor-I and its binding proteins in the follow-up of acromegaly. Wass JA J Endocrinol; 1997 Oct; 155 Suppl 1():S17-9; discussion S21. PubMed ID: 9389991 [TBL] [Abstract][Full Text] [Related]
6. Short-term suppression of elevated growth hormone concentrations following insulin-like growth factor 1 administration in young adults with type 1 diabetes does not alter glomerular filtration or albumin excretion rates. Williams RM; Yuen K; White D; Mallard B; Dalton RN; Acerini CL; Dunger DB Clin Endocrinol (Oxf); 2006 Oct; 65(4):439-45. PubMed ID: 16984235 [TBL] [Abstract][Full Text] [Related]
7. Diabetic nephropathy: has the time come to move beyond plasma creatinine? Osman MM; Ahmed MH Ren Fail; 2006; 28(6):525-6. PubMed ID: 16928625 [No Abstract] [Full Text] [Related]
8. Acromegaly and heart failure: revisions of the growth hormone/insulin-like growth factor axis and its relation to the cardiovascular system. Twickler TB; Cramer MJ; Senden SP; Doevendans PA; de Vries WR; Erkelens DW; Koppeschaar HP Semin Vasc Med; 2004 May; 4(2):115-20. PubMed ID: 15478031 [TBL] [Abstract][Full Text] [Related]
9. Growth hormone excess and the effect of octreotide in cats with diabetes mellitus. Slingerland LI; Voorhout G; Rijnberk A; Kooistra HS Domest Anim Endocrinol; 2008 Nov; 35(4):352-61. PubMed ID: 18801640 [TBL] [Abstract][Full Text] [Related]
11. Determination of free insulin-like growth factor-I in human serum: comparison of ultrafiltration and direct immunoradiometric assay. Frystyk J; Ivarsen P; Støving RK; Dall R; Bek T; Hagen C; Ørskov H Growth Horm IGF Res; 2001 Apr; 11(2):117-27. PubMed ID: 11472078 [TBL] [Abstract][Full Text] [Related]
12. Lipoprotein(a) and atherosclerotic disease in insulin-dependent diabetic patients with declining glomerular filtration rate. Earle KA; Mattock M; Morocutti A; Aravanitis D; Viberti GC Diabet Med; 1996 Dec; 13(12):1071-2. PubMed ID: 8973890 [No Abstract] [Full Text] [Related]
13. Decrease in growth hormone and insulin-like growth factor (IGF)-1 release and amelioration of acromegaly features after rosiglitazone treatment of type 2 diabetes mellitus a patient with acromegaly. Gradiser M; Matovinovic M; Vrkljan M Croat Med J; 2007 Feb; 48(1):87-91. PubMed ID: 17309144 [TBL] [Abstract][Full Text] [Related]
14. On the pathogenesis of the increased glomerular filtration rate in short-term insulin-dependent diabetes. Christiansen JS Dan Med Bull; 1984 Oct; 31(5):349-61. PubMed ID: 6391846 [No Abstract] [Full Text] [Related]
15. The nadir growth hormone after an octreotide test dose predicts the long-term efficacy of somatostatin analogue therapy in acromegaly. Gilbert JA; Miell JP; Chambers SM; McGregor AM; Aylwin SJ Clin Endocrinol (Oxf); 2005 Jun; 62(6):742-7. PubMed ID: 15943838 [TBL] [Abstract][Full Text] [Related]
16. Effects of treatment with somatostatin analogues on QT interval duration in acromegalic patients. Fatti LM; Scacchi M; Lavezzi E; Pecori Giraldi F; De Martin M; Toja P; Michailidis G; Stramba-Badiale M; Cavagnini F Clin Endocrinol (Oxf); 2006 Nov; 65(5):626-30. PubMed ID: 17054464 [TBL] [Abstract][Full Text] [Related]
17. Urinary epidermal growth factor excretion is correlated to renal function loss per se and not to the degree of diabetic renal failure. ter Meulen CG; Bilo HJ; van Kamp GJ; Gans RO; Donker AJ Neth J Med; 1994 Jan; 44(1):12-7. PubMed ID: 8202200 [TBL] [Abstract][Full Text] [Related]
18. [The place of insulin-like growth factor I in the diagnosis of acromegaly]. Dohán O; Góth M; Szabolcs I; Kovács L; Kovács Z; Szilágyi G Orv Hetil; 1993 Oct; 134(42):2301-3. PubMed ID: 8233444 [TBL] [Abstract][Full Text] [Related]
19. Octreotide stimulates insulin-like growth factor binding protein-1: a novel mechanism of drug action on acromegaly. Melmed S Semin Oncol; 1994 Oct; 21(5 Suppl 13):65-9. PubMed ID: 7527593 [No Abstract] [Full Text] [Related]
20. Recent advances in diabetic nephropathy: how big a culprit is glucose? Striker GE; Striker LJ Diabetes Metab; 1996 Dec; 22(6):407-14. PubMed ID: 8985648 [No Abstract] [Full Text] [Related] [Next] [New Search]